Found: 16
Select item for more details and to access through your institution.
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2012, v. 26, n. 11, p. 1444, doi. 10.1111/j.1468-3083.2011.04216.x
- By:
- Publication type:
- Article
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2010, v. 24, n. 5, p. 555, doi. 10.1111/j.1468-3083.2009.03464.x
- By:
- Publication type:
- Article
First case of secukinumab successful therapy in a very elderly psoriatic patient.
- Published in:
- Dermatologic Therapy, 2018, v. 31, n. 5, p. N.PAG, doi. 10.1111/dth.12668
- By:
- Publication type:
- Article
Reduction in psoriasis related pruritus during biologic therapy.
- Published in:
- Dermatologic Therapy, 2017, v. 30, n. 3, p. n/a, doi. 10.1111/dth.12442
- By:
- Publication type:
- Article
Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result.
- Published in:
- Dermatologic Therapy, 2013, v. 26, n. 1, p. 77, doi. 10.1111/j.1529-8019.2012.01539.x
- By:
- Publication type:
- Article
Itch in psoriasis: epidemiology, clinical aspects and treatment options.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2009, v. 2, p. 9
- By:
- Publication type:
- Article
Lichen planus triggered by CT‐P13 and recurrence during secukinumab treatment.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Clinical experience with infliximab biosimilar in psoriasis.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
- Published in:
- British Journal of Dermatology, 2011, v. 164, n. 3, p. 645, doi. 10.1111/j.1365-2133.2010.10140.x
- By:
- Publication type:
- Article
Induced Preference Improves Offspring Fitness in a Phytopathogen Vector.
- Published in:
- Environmental Entomology, 2017, v. 46, n. 5, p. 1090, doi. 10.1093/ee/nvx135
- By:
- Publication type:
- Article
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, p. 21, doi. 10.1111/jdv.15825
- By:
- Publication type:
- Article
Risk of acute infections in psoriatic patients during biologic therapies is linked to gender.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 10, p. e362, doi. 10.1111/jdv.15658
- By:
- Publication type:
- Article
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 11, p. e486, doi. 10.1111/jdv.14300
- By:
- Publication type:
- Article
Clinical characteristics of psoriasis in inflammatory bowel disease patients.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 9, p. e414, doi. 10.1111/jdv.14230
- By:
- Publication type:
- Article